1. Home
  2. BYND vs DRUG Comparison

BYND vs DRUG Comparison

Compare BYND & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$0.91

Market Cap

447.4M

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$82.12

Market Cap

364.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYND
DRUG
Founded
2009
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Pharmaceuticals and Biotechnology
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.4M
364.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BYND
DRUG
Price
$0.91
$82.12
Analyst Decision
Sell
Strong Buy
Analyst Count
7
8
Target Price
$1.70
$83.00
AVG Volume (30 Days)
85.8M
157.9K
Earning Date
11-10-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$290,565,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$23.18
52 Week High
$7.69
$97.75

Technical Indicators

Market Signals
Indicator
BYND
DRUG
Relative Strength Index (RSI) 39.00 56.87
Support Level $0.96 $77.80
Resistance Level $1.26 $89.71
Average True Range (ATR) 0.11 8.40
MACD -0.00 -0.81
Stochastic Oscillator 0.67 32.52

Price Performance

Historical Comparison
BYND
DRUG

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: